Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC) - PubMed (original) (raw)
Clinical Trial
doi: 10.1007/BF02049478.
Affiliations
- PMID: 8603558
- DOI: 10.1007/BF02049478
Clinical Trial
Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC)
R Caprilli et al. Dis Colon Rectum. 1996 Mar.
Abstract
Prognostic factors for postoperative recurrence of Crohn's disease (CD) have been widely investigated but not yet clearly identified.
Purpose: Aim of this study was, therefore, to analyze the association between demographic, clinical, laboratory, and surgical characteristics of patients and the cumulative probability of endoscopic postoperative recurrence.
Methods: The study was performed in 110 patients who were enrolled in the Italian multicenter, randomized, controlled trial on the effectiveness of 5-aminosalicylic acid (5-ASA) in the prevention of postoperative recurrence in CD. Patients had undergone their first intestinal resection for CD of the terminal ileum with or without involvement of cecum ascending colon. Recurrence was defined on the basis of endoscopy. The following variables were evaluated as potential prognostic factors: gender, age, years since diagnosis, clinical course (perforative and non-perforative), Crohn's Disease Activity Index score, white blood count, erythrocyte sedimentation rate, C-reactive protein, and orosomucoids assessed before the operation. Timing of operation (elective or urgent), type of anastomosis (end-to-end, end-to-side, side-to-side), and prophylactic treatment were also evaluated. Colon ileoscopy was performed at 6, 12, 24, and 36 months after operation. The association between variables and the cumulative proportion of recurrence was analyzed both by univariate analysis (life table method, log-rank test) and multivariate regression analysis (Cox's model, stepwise procedure).
Results: Results of this study indicate that, of the features considered before surgery, only leukocytosis (white blood count, >9,000 ml) was significantly associated with an increased risk of recurrence (P < 0.05) at univariate analysis. This finding was not confirmed by multivariate analysis. A trend toward a higher risk of recurrence for patients who have had a resection with end-to-end anastomosis compared with those who have had a resection and other types of anastomosis was also observed. This trend reached significantly in the group of patients submitted to treatment with 5-ASA. The multivariate analysis showed that 5-ASA-treated patients with end-to-end had a risk of recurrence more than threefold higher than those with other types of anastomosis (relative risk, 3.40; 95 percent confidence interval, 1.00-11.96; P < 0.03).
Conclusions: From a practical point of view, it has been estimated that the combination of intestinal resection plus side-to-side or end-to-side anastomosis with oral 5-ASA treatment reduces by 64 percent the postoperative recurrence rate in CD at three years follow-up.
Similar articles
- Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del Retto.
Frieri G, Pimpo MT, Palumbo G, Tonelli F, Annese V, Sturniolo GC, Andreoli A, Comberlato M, Corrao G, Caprilli R. Frieri G, et al. Am J Gastroenterol. 2000 Jun;95(6):1486-90. doi: 10.1111/j.1572-0241.2000.2083_1.x. Am J Gastroenterol. 2000. PMID: 10894584 - Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).
Caprilli R, Andreoli A, Capurso L, Corrao G, D'Albasio G, Gioieni A, Assuero Lanfranchi G, Paladini I, Pallone F, Ponti V, et al. Caprilli R, et al. Aliment Pharmacol Ther. 1994 Feb;8(1):35-43. doi: 10.1111/j.1365-2036.1994.tb00158.x. Aliment Pharmacol Ther. 1994. PMID: 8186345 Clinical Trial. - "Crohn's disease activity index" is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study. Gruppo Italiano per lo Studio del Colon e del Retto.
Viscido A, Corrao G, Taddei G, Caprilli R. Viscido A, et al. Ital J Gastroenterol Hepatol. 1999 May;31(4):274-9. Ital J Gastroenterol Hepatol. 1999. PMID: 10425569 Clinical Trial. - Strategies for the prevention of postoperative recurrence of Crohn's disease.
Yamamoto T, Watanabe T. Yamamoto T, et al. Colorectal Dis. 2013 Dec;15(12):1471-80. doi: 10.1111/codi.12326. Colorectal Dis. 2013. PMID: 23809911 Review. - In favour of prophylactic treatment for post-operative recurrence in Crohn's disease.
Caprilli R, Taddei G, Viscido A. Caprilli R, et al. Ital J Gastroenterol Hepatol. 1998 Apr;30(2):219-25. Ital J Gastroenterol Hepatol. 1998. PMID: 9675663 Review.
Cited by
- The Right to Oncological Oblivion: A Legislative Response to Cancer Survivor Discrimination in Italy.
D'Antonio G, Bolino G, Sorace L, Volonnino G, Pellegrini L, Di Fazio N, Frati P. D'Antonio G, et al. Healthcare (Basel). 2024 Aug 21;12(16):1665. doi: 10.3390/healthcare12161665. Healthcare (Basel). 2024. PMID: 39201223 Free PMC article. - Management of Post-Operative Crohn's Disease: Knowns and Unknowns.
Spertino M, Gabbiadini R, Dal Buono A, Busacca A, Franchellucci G, Migliorisi G, Repici A, Spinelli A, Bezzio C, Armuzzi A. Spertino M, et al. J Clin Med. 2024 Apr 16;13(8):2300. doi: 10.3390/jcm13082300. J Clin Med. 2024. PMID: 38673573 Free PMC article. Review. - Prevention and Treatment Options for Postoperative Crohn's Disease: A Clinical Dilemma.
Clarke K, Regueiro M. Clarke K, et al. Gastroenterol Hepatol (N Y). 2009 Aug;5(8):581-588. Gastroenterol Hepatol (N Y). 2009. PMID: 37967435 Free PMC article. - Anastomotic Configuration and Temporary Diverting Ileostomy Do Not Increase Risk of Anastomotic Stricture in Postoperative Crohn's Disease.
Bachour SP, Khan MZ, Shah RS, Joseph A, Syed H, Ali AH, Rieder F, Holubar SD, Barnes EL, Axelrad J, Regueiro M, Cohen BL, Click BH. Bachour SP, et al. Am J Gastroenterol. 2023 Dec 1;118(12):2212-2219. doi: 10.14309/ajg.0000000000002393. Epub 2023 Jul 7. Am J Gastroenterol. 2023. PMID: 37410924 - Predictors of postoperative recurrence in a cohort of Tunisian patients with Crohn's disease.
Hammami A, Harbi R, Elleuch N, Meddeb KB, Ameur WB, Dahmani W, Braham A, Ajmi S, Ksiaa M, Slama AB, Jaziri H, Jmaa A. Hammami A, et al. Ther Adv Gastrointest Endosc. 2022 Mar 19;15:26317745211060689. doi: 10.1177/26317745211060689. eCollection 2022 Jan-Dec. Ther Adv Gastrointest Endosc. 2022. PMID: 35321255 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials